The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The approval is for Cytomegalovirus, a type of Herpes virus
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
The programme will be implemented across 13 states and benefit 256 min
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
Subscribe To Our Newsletter & Stay Updated
